Qiagen (QGEN) Reports In-Line Q4 EPS, Revenues Miss

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 11/4/2026

1. AMD
2. AMGN
3. BKNG
4. DOX
5. DUOL
6. ANET
7. XYZ
8. SWKS
9. SPY
10. FISV

Go back to Qiagen (QGEN) Reports In-Line Q4 EPS, Revenues Miss

QIAGEN Reports Results for Fourth Quarter and Full-Year 2018

February 4, 2019 4:04 PM EST

QIAGEN delivers on full-year 2018 outlook FY 2018: Achieved 6% CER net sales growth to $1.5 billion vs. ~6-7% CER outlook and adj. diluted EPS of $1.34 ($1.35 CER vs. ~$1.33-1.34 CER outlook) FY 2018: Adj. operating income margin rises to 27% of sales from 26% in 2017 and operating cash flow rises 25% to $359.5 million Q4 2018: Net sales of $403.2 million +2%, +5% CER vs. ~6-7% CER outlook; diluted EPS of $0.26; adj. EPS $0.40 ($0.41 CER vs. ~$0.39-0.40 CER outlook) Delivering 2018 growth from dynamic and disruptive Sample to Insight portfolio QuantiFERON-TB delivers 21% CER full-year growth... More